Coeptis Therapeutics Holdings, Inc.
Recent Filings
All 307 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 424B3 | PROSPECTUS SUPPLEMENT NO. 12 | Mar 23, 2026 |
| 424B3 | PROSPECTUS SUPPLEMENT NO. 5 | Mar 23, 2026 |
| 424B3 | PROSPECTUS SUPPLEMENT NO. 10 | Mar 23, 2026 |
| 10-K | FORM 10-K FOR DEC 2025 | Mar 19, 2026 |
| 4 | — | Feb 13, 2026 |
| 4 | — | Feb 13, 2026 |
| 4 | — | Feb 13, 2026 |
| 4 | — | Feb 13, 2026 |
| 4 | — | Feb 13, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| DeSilva Tara | — | Purchase | 1,800 @ $0.58 | 32,266 | Jan 12, 2024 |
| Cogley Brian | Chief Financial Officer | Purchase | 5,000 @ $0.67 | 30,000 | Jan 10, 2024 |
| Mehalick David | CEO and President | Purchase | 5,050 @ $0.69 | 2,762,611 | Jan 8, 2024 |
| Yerace Daniel Alexander | VP of Operations | Purchase | 10,850 @ $0.69 | 1,071,455 | Jan 5, 2024 |
| Salkind Gene | — | Purchase | 11,600 @ $0.69 | 284,056 | Jan 5, 2024 |
| Cochran Christopher P. | — | Purchase | 7,000 @ $0.77 | 37,000 | Jan 5, 2024 |
| Salkind Gene | — | Purchase | 28,638 @ $0.91 | 28,638 | Aug 29, 2023 |
| Calise Chris | — | Purchase | 2,582 @ $0.94 | 1,464,897 | Aug 23, 2023 |
| Harraden Circle Investors GP, LP | — | Sale | 85,305 @ $10.11 | 429,131 | May 4, 2022 |
| GLAZER CAPITAL, LLC | — | Sale | 50,000 @ $9.85 | 1,016,500 | May 26, 2021 |